Patent details
LUC00187 Product Name: isatuximab
Basic Information
- Publication number:
- LUC00187
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP138614706
- Legal Status:
- Inactive
- Application number:
- LUC00187
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/20/1435
- Marketing Authorization Type:
- Marketing Authorization Date:
- 03/06/2020
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 25/11/2020
- First Marketing Authorization date:
- 03/06/2020
- Grant date:
- 01/07/2024
- Activation date:
- Publication date:
- 25/11/2020
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 03/06/2035
- SPC Extension Expiration:
- 03/06/2035
- Rejection date:
- Withdrawal date:
Owner
- From:
- 25/11/2020
- Name:
- SANOFI
- Address:
- 54, rue La Boétie, 75008 Paris, France (FR)
- Name:
- The Regents of the University of California
- Address:
- 1111 Franklin Street, 12th Floor, Oakland, CA 94607, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 25/11/2020
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2020/13
- Publication date:
- 07/12/2020
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/10
- Publication date:
- 06/08/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Other
- Note:
- suspension levée par lettre du 15/09/2023
Annual Fees
- Annual Fee Due Date:
- 02/01/2034
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 15/09/2023 | Incoming Correspondence (Post) | 1 |
| 25/11/2020 | Marketing authorization | 3 |
| 25/11/2020 | MA publication | 2 |
| 25/11/2020 | Summary of the product caracteristics | 35 |
| 28/05/2021 | Incoming Correspondence (Post) | 1 |
| 25/11/2020 | Outgoing Correspondence | 1 |
| 25/11/2020 | Application Form | 4 |
| 25/11/2020 | Incoming Correspondence (Post) | 1 |
| 07/03/2024 | Outgoing Correspondence | 1 |
| 25/11/2020 | Publication | 1 |
| 01/07/2024 | Publication | 1 |
| 01/07/2024 | Certificate | 1 |
| 08/07/2024 | Outgoing Correspondence | 1 |